Gross Profit Trends Compared: Amneal Pharmaceuticals, Inc. vs Perrigo Company plc

Pharma Giants' Profit Trends: Amneal vs. Perrigo

__timestampAmneal Pharmaceuticals, Inc.Perrigo Company plc
Wednesday, January 1, 20144496340001447700000
Thursday, January 1, 20154992260001712400000
Friday, January 1, 20165974550002051800000
Sunday, January 1, 20175261780001979500000
Monday, January 1, 20187164030001831500000
Tuesday, January 1, 20193529970001773300000
Wednesday, January 1, 20206283930001815200000
Friday, January 1, 20217689730001416200000
Saturday, January 1, 20227847080001455400000
Sunday, January 1, 20238205650001680400000
Loading chart...

Unleashing the power of data

Gross Profit Trends: Amneal Pharmaceuticals vs. Perrigo Company

In the ever-evolving pharmaceutical industry, understanding financial trends is crucial. Over the past decade, Amneal Pharmaceuticals, Inc. and Perrigo Company plc have shown distinct trajectories in their gross profit margins. From 2014 to 2023, Amneal's gross profit surged by approximately 82%, reflecting its strategic growth and market adaptation. In contrast, Perrigo, while maintaining a higher gross profit overall, experienced a more modest increase of around 16% during the same period.

Amneal's most significant leap occurred between 2018 and 2023, with a 15% rise, showcasing its resilience and innovation in a competitive market. Meanwhile, Perrigo's peak in 2016, followed by a slight decline, indicates challenges in sustaining its earlier momentum. These trends highlight the dynamic nature of the pharmaceutical sector, where strategic decisions and market conditions play pivotal roles in shaping financial outcomes.

Published by
U.S. Securities and Exchange Commission

Source link
sec.gov

Date published
17 Jan 2025